Amgen said Thursday that its cholesterol-lowering shot, Repatha, prevented a composite of heart disease death, heart attack, and the most common type of stroke in a 12,000-patient trial. Analysts have said that the results of the study could help the drug, which has been available since 2015 to reduce cholesterol, reach a broader market. That represents a comeback story for …
Read More »Amgen says cholesterol shot prevented heart problems in a broad population
